Screen to Save: A Colorectal Cancer Educational Intervention

Overview

The purpose of this research is to understand if an educational program about colorectal cancer helps improve people's knowledge of colorectal cancer prevention and screening and their intention to get screened for colorectal cancer.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Screening
    • Masking: None (Open Label)
  • Study Primary Completion Date: September 30, 2020

Interventions

  • Behavioral: Inflatable colon educational module
    • Participants attend a brief educational presentation in an inflatable colon, learning about colorectal cancer prevention and screening.

Arms, Groups and Cohorts

  • Experimental: Inflatable colon educational module
    • Participants attend a brief educational presentation in an inflatable colon, focused on colorectal cancer prevention and screening. Participants also receive a copy of the study information sheet and may receive written educational materials to take home. Participants complete a pre-test and a post-test to assess changes in knowledge and intention to get screened for colorectal cancer.

Clinical Trial Outcome Measures

Primary Measures

  • Change in knowledge related to colorectal cancer risk, prevention, and screening
    • Time Frame: Baseline and Immediately following intervention
    • A pre-test and post-test is conducted with participants to assess any changes in knowledge related to key learning outcomes expected from the educational intervention (assessed via 14 questions before and after learning).
  • Strength of behavioral intentions related to colorectal cancer
    • Time Frame: Immediately following intervention
    • Post-test conducted to assess behavioral intention related to five prevention and screening behaviors (assessed via 5 questions on a 4-point Likert scale, where a lower score indicates stronger behavioral intention).

Participating in This Clinical Trial

Inclusion Criteria

  • Age: 50-74 years old
  • Attendee at event where educational module is offered

Gender Eligibility: All

Minimum Age: 50 Years

Maximum Age: 74 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Dartmouth-Hitchcock Medical Center
  • Collaborator
    • National Cancer Institute (NCI)
  • Provider of Information About this Clinical Study
    • Principal Investigator: Tracy L. Onega, Associate Director of Community Outreach and Education, Norris Cotton Cancer Center; Associate Professor, Dartmouth Geisel School of Medicine – Dartmouth-Hitchcock Medical Center

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.